RUNX1 and acute lymphoblastic leukemia: Moreover, we demonstrated that addition of a CBFA2T3-domain NHR2 hampers the interaction between RUNX1 and CBFA2T3, dramatically inhibits RUNX1 transcription activity, and slows down BCP ALL-cell proliferation.